Clonidine Uses the Brain's Opioid System to Lower Blood Pressure — But Only in Hypertension
Clonidine's blood-pressure-lowering effect involves beta-endorphin and dynorphin in the brain only in hypertensive rats — this opioid mechanism is absent in rats with normal blood pressure.
Quick Facts
What This Study Found
Clonidine's central hypotensive mechanism involves beta-endorphin and dynorphin only in spontaneously hypertensive rats, not in normotensive Wistar-Kyoto rats.
Key Numbers
How They Did This
Conscious hypertensive and normotensive rats received intracisternal pretreatment with opioid antagonists or antisera, followed by cumulative intracisternal clonidine. Blood pressure and heart rate were measured.
Why This Research Matters
This suggests the opioid system plays a special role in blood pressure regulation during hypertension. The mechanism is fundamentally different in normal versus high blood pressure states.
The Bigger Picture
This study revealed that the opioid peptide system is activated differently during disease states. The brain appears to recruit additional signaling pathways during hypertension that are not active under normal conditions. This has implications for understanding why the same drug may work through different mechanisms in different patients.
What This Study Doesn't Tell Us
Used a specific genetic model of hypertension (SHR). Other types of hypertension may involve different mechanisms. Brain injection does not reflect clinical drug delivery.
Questions This Raises
- ?Does the opioid involvement in clonidine's mechanism apply to human hypertension?
- ?Are other antihypertensive drugs also using disease-state-specific opioid mechanisms?
Trust & Context
- Key Stat:
- Hypertension-specific mechanism Opioid peptide involvement in clonidine's effect was present only in spontaneously hypertensive rats, absent in normotensive controls
- Evidence Grade:
- Preliminary animal study using a specific genetic hypertension model. The disease-state-specific finding is compelling but needs validation in other models.
- Study Age:
- Published in 1989. Clonidine remains in clinical use, and the concept of disease-state-specific drug mechanisms continues to influence pharmacology.
- Original Title:
- Possible involvement of brain opioid peptides in clonidine-induced hypotension in spontaneously hypertensive rats.
- Published In:
- Hypertension (Dallas, Tex. : 1979), 13(1), 83-90 (1989)
- Authors:
- van Giersbergen, P L(5), Tierney, S A, Wiegant, V M(3), de Jong, W
- Database ID:
- RPEP-00142
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why does the opioid mechanism only appear in hypertension?
During chronic hypertension, the brain's blood pressure control circuits likely undergo changes that increase opioid peptide involvement. The opioid pathway may be a compensatory mechanism that is dormant under normal conditions.
What is clonidine used for?
Clonidine is a medication that acts on the brain to lower blood pressure. It's also used for ADHD, anxiety, and opioid withdrawal. This study showed that part of its blood pressure effect involves the brain's own opioid peptide system.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00142APA
van Giersbergen, P L; Tierney, S A; Wiegant, V M; de Jong, W. (1989). Possible involvement of brain opioid peptides in clonidine-induced hypotension in spontaneously hypertensive rats.. Hypertension (Dallas, Tex. : 1979), 13(1), 83-90.
MLA
van Giersbergen, P L, et al. "Possible involvement of brain opioid peptides in clonidine-induced hypotension in spontaneously hypertensive rats.." Hypertension (Dallas, 1989.
RethinkPeptides
RethinkPeptides Research Database. "Possible involvement of brain opioid peptides in clonidine-i..." RPEP-00142. Retrieved from https://rethinkpeptides.com/research/van-1989-possible-involvement-of-brain
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.